Wang Hao, Xiong Wei, Laram Yongchu, Hu Li, Zhong Wu, Hu Yingchun
Clinical Medical College, Southwest Medical University, Luzhou, People's Republic of China.
Department of Emergency Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China.
BMC Complement Med Ther. 2024 Oct 1;24(1):347. doi: 10.1186/s12906-024-04637-5.
To explore, using network pharmacology and RNA-seq technologies, potential active targets and mechanisms underpinning Radix Bupleuri's effectiveness during sepsis treatment.
Following the Sepsis-3.0 criteria, the research cohort, comprising 23 sepsis patients and 10 healthy participants, was obtained from public databases. Peripheral blood samples were collected and subjected to RNA-seq analysis. Active ingredients and potential targets of Radix Bupleuri were identified using the Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine 2.0 (BATMAN-TCM 2.0) database and TCMSP database. Subsequently, protein-protein interaction (PPI) network construction, Gene Ontology (GO) analysis, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were conducted to explore cross-targets between disease and drugs. Survival analysis of key targets was performed using the GSE65682 dataset, and single-cell RNA-seq was employed for cellular localization analysis of key genes. Finally, molecular docking and Molecular dynamics simulation of the core target was conducted.
Differential expression analysis revealed 4253 genes associated with sepsis. Seventy-six active components and 1030 potential targets of Radix Bupleuri were identified. PPI, GO, and pathway enrichment analyses indicated involvement in the regulation of transmembrane transport, monatomic ion transport, and MAPK signaling. Survival curve analysis identified PIK3CD, ARRB2, SUCLG1, and SPI1 as key targets associated with lower mortality in the high expression group, while higher mortality was observed in the high PNP and FURIN expression groups. Single-cell RNA sequencing unveiled the cellular localization of PIK3CD, PNP, SPI1, and FURIN within macrophages, while ARRB2 and SUCLG1 exhibited localization in both macrophages and T-cells. Subsequent molecular docking and Molecular dynamics simulation indicated a potential binding interaction for Carvone-PIK3CD, Encecalin-ARRB2, Lauric Acid-SUCLG1, Pulegone-FURIN, Nootkatone-SPI1, and Saikogenin F-PNP.
Radix Bupleuri could modulate immune function by affecting PIK3CD, ARRB2, SUCLG1, FURIN, SPI1, and PNP, thereby potentially improving the prognosis of sepsis.
运用网络药理学和RNA测序技术,探索柴胡在脓毒症治疗中发挥作用的潜在活性靶点及机制。
依据脓毒症3.0标准,从公共数据库获取由23例脓毒症患者和10名健康参与者组成的研究队列。采集外周血样本并进行RNA测序分析。利用中药分子机制生物信息分析工具2.0(BATMAN-TCM 2.0)数据库和TCMSP数据库鉴定柴胡的活性成分和潜在靶点。随后,进行蛋白质-蛋白质相互作用(PPI)网络构建、基因本体(GO)分析和京都基因与基因组百科全书(KEGG)通路富集分析,以探索疾病与药物之间的交叉靶点。使用GSE65682数据集对关键靶点进行生存分析,并采用单细胞RNA测序对关键基因进行细胞定位分析。最后,对核心靶点进行分子对接和分子动力学模拟。
差异表达分析揭示了4253个与脓毒症相关的基因。鉴定出柴胡的76种活性成分和1030个潜在靶点。PPI、GO和通路富集分析表明其参与跨膜转运、单原子离子转运和MAPK信号传导的调控。生存曲线分析确定PIK3CD、ARRB2、SUCLG1和SPI1为高表达组中与较低死亡率相关的关键靶点,而PNP和FURIN高表达组的死亡率较高。单细胞RNA测序揭示了PIK3CD、PNP、SPI1和FURIN在巨噬细胞内的细胞定位,而ARRB2和SUCLG1在巨噬细胞和T细胞中均有定位。随后的分子对接和分子动力学模拟表明香芹酮与PIK3CD、恩卡琳与ARRB2、月桂酸与SUCLG1、长叶薄荷酮与FURIN、诺卡酮与SPI1以及柴胡皂苷F与PNP之间存在潜在的结合相互作用。
柴胡可能通过影响PIK3CD、ARRB2、SUCLG1、FURIN、SPI1和PNP来调节免疫功能,从而可能改善脓毒症的预后。